The general approach to rabies treatment serves as a model for a more complex ... infection of 2.5–5 million people by a respiratory virus conferring 1–2% mortality and exceeds the annual ...
The company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback